-
Cardiogenesis Corporation (OTCQB: CGCP), released comments regarding the STAR-heart study......
-
Three new analyses of subgroups from the SORT OUT III study presented at the European Society of Cardiology (ESC) meeting in Stockholm, Sweden, provide additional detail on longer-term follow-up subgroup safety and efficacy outcomes in the SORT OUT III trial in three high-risk subgroups (diabetes, acute coronary syndrome and multiple ...
-
A double-dose of the anti-clotting treatment clopidogrel, also known as Plavix, significantly reduces complications in heart patients undergoing angioplasty to clear blocked arteries. Shamir R. Mehta, an interventional cardiologist and associate professor of medicine of the Michael G......
-
MSD (known in the US and Canada as Merck) (NYSE:MRK) and Cardiome Pharma Corp. (NASDAQ: CRME/ TSX: COM) announced that the intravenous (IV) formulation of BRINAVESS™ (vernakalant) has been granted marketing approval in the European Union (EU), Iceland and Norway for the conversion of recent onset atrial fibrillation (AF) to ...
-
As families return to the frenzied back-to-school pace, the American Heart Association is urging Hispanics to make time for the most important test they can take: a simple online health assessment to help them avoid heart disease and stroke......
-
Merck (known as MSD outside the United States and Canada) (NYSE:MRK) and Cardiome Pharma Corp......
-
InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) to market the LipiScan™ IVUS Coronary Imaging System......
-
Sibutramine, brand name Meridia is an appetite suppressant, a weight loss pill. Editors at the NEJM (New England Journal of Medicine) write it is difficult for them to discern a "credible rationale for keeping this medication on the market", even though it is restricted for people without heart disease......
-
St. Jude Medical, Inc. (NYSE:STJ) applauds the updated class and level of evidence for Fractional Flow Reserve (FFR)-guided treatment in the Guidelines on Percutaneous Coronary Intervention (PCI) announced Monday at the European Society of Cardiology (ESC) congress in Stockholm......
-
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), announced that the investigational, oral anticoagulant rivaroxaban successfully demonstrated non-inferiority compared to the standard of care1 for the prevention of recurrent venous thromboembolism (VTE) in patients with acute symptomatic deep vein thrombosis (DVT), with a comparable safety profile......
-
A study of the body system that deals with Americans' love affair with salt may yield more insight into why so many end up hypertensive and how to better treat them. A team of scientists from the Medical College of Georgia, the University of Utah and the University of Texas ...
-
Atrial Fibrillation (A Fib) a type of heart rhythm disorder that affects the electrical system, or "wiring," of the heart muscle is often referred to as the "silent killer," and can suddenly trigger a massive, debilitating stroke or even death. During September National Atrial Fibrillation Awareness Month physicians at the ...
-
One in 20 Americans over age 50 has Peripheral Artery Disease (PAD), a condition that robs them of their independence and mobility by increasing the risk of heart attack, stroke, amputation and death. The Society for Vascular Medicine (SVM) is working to increase awareness of PAD, its diagnosis and treatment......
-
A new study suggests yet another reason for Americans to abandon their current fatty diets in favor of one rich in fruits and vegetables and low in saturated fat. Choosing these healthier options appears to significantly reduce the long-term risk of heart disease in patients with mildly elevated blood pressure, ...
-
A study carried out by cardiologists from the Medical University of Innsbruck has investigated the risk of myocardial infarction (heart attack) amongst winter sports tourists to the Tyrolean Alps......
-
A detailed study conducted by a team from the University of Athens on the Aegean island of Ikaria has demonstrated that moderate consumption of coffee by hypertensive elderly individuals can lead to improvements in aortic distensibility......
-
The University of Athens Medical School has conducted a comprehensive study to evaluate the relationship between diet quality, levels of physical activity and key lifestyle characteristics amongst a group of 12-17 year old schoolchildren. The objective was to determine the most appropriate health actions to reduce the risks of long-term ...
-
The DASH eating plan, known to reduce blood pressure and bad cholesterol, also reduces the 10-year risk of heart attack, especially among African-Americans, according to research reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal......
-
Masimo (Nasdaq: MASI) announced that a new randomized controlled trial published in Anesthesia & Analgesia shows that clinicians using Masimo Pleth Variability Index (PVI®) significantly improved fluid management and reduced lactate levels in patients during and after surgery, compared to patients managed by standard care without PVI(1)......
-
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced at European Society of Cardiology in Stockholm that the results of follow-up tests undertaken ten years after the first patient was treated with a CYPHER(R) Sirolimus-eluting coronary stent have proven outstanding long-term efficacy and safety ...
